Filter News
Area of Research
News Topics
- (-) Coronavirus (25)
- (-) National Security (2)
- 3-D Printing/Advanced Manufacturing (28)
- Advanced Reactors (14)
- Artificial Intelligence (8)
- Big Data (11)
- Bioenergy (13)
- Biology (5)
- Biomedical (22)
- Biotechnology (2)
- Buildings (1)
- Chemical Sciences (5)
- Clean Water (2)
- Composites (1)
- Computer Science (39)
- Critical Materials (2)
- Cybersecurity (4)
- Energy Storage (21)
- Environment (29)
- Exascale Computing (3)
- Frontier (1)
- Fusion (13)
- Grid (7)
- High-Performance Computing (3)
- Isotopes (8)
- Machine Learning (8)
- Materials (2)
- Materials Science (37)
- Mathematics (2)
- Mercury (1)
- Microscopy (8)
- Molten Salt (2)
- Nanotechnology (17)
- Neutron Science (35)
- Nuclear Energy (31)
- Physics (13)
- Polymers (7)
- Quantum Science (14)
- Security (3)
- Space Exploration (2)
- Summit (17)
- Transportation (15)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 27 Results

Jeff Johnson, nonproliferation research and development integration manager for ORNL’s National Security Sciences Directorate, has been honored by the American Nuclear Society

Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.

The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial

A multi-institutional team, led by a group of investigators at 91°µÍø, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.

Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.

NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s 91°µÍø that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.

To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A collaboration between the ORNL and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.

Growing up in Florida, Emma Betters was fascinated by rockets and for good reason. Any time she wanted to see a space shuttle launch from NASA’s nearby Kennedy Space Center, all she had to do was sit on her front porch.

Experts at the Department of Energy’s 91°µÍø are now offering short-term technical and scientific assistance to entities working to combat the coronavirus through the COVID-19 Technical Assistance Program, an initiative of DOE’s Office of Technology Transitions.